Point Therapeutics Overview
- Year Founded
-
1993
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Point Therapeutics General Information
Description
Operator of a biopharmaceutical company based in Wellesley, Massachusetts. The company's lead product candidate was tablostat, for which it conducted clinical studies for advanced non-small cell lung cancer, as well as in combination with other drugs to treat metastatic melanoma, chronic lymphocytic leukemia and Stage IV pancreatic cancer.
Contact Information
Website
www.pointtherapeutics.comCorporate Office
- 70 Walnut Street
- Wellesley, MA 02481
- United States
Corporate Office
- 70 Walnut Street
- Wellesley, MA 02481
- United States
Point Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Point Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Point Therapeutics Patents
Point Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2008066729-A2 | Boronic acid containing compositions | Inactive | 22-Nov-2006 | ||
| WO-2008033368-A2 | Boroproline compound and cytokine combination therapy | Inactive | 12-Sep-2006 | ||
| WO-2007127204-A2 | Methods and compositions relating to immunostimulation | Inactive | 24-Apr-2006 | ||
| WO-2007123686-A2 | Dpp inhibitors and uses thereof | Inactive | 31-Mar-2006 | ||
| WO-2007123686-A3 | Dpp inhibitors and uses thereof | Inactive | 31-Mar-2006 | C07F5/025 |
Point Therapeutics Acquisitions (1)
Point Therapeutics’s most recent deal was a Reverse Merger with Fortovia Therapeutics. The deal was made on 12-Feb-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fortovia Therapeutics | 12-Feb-2008 | Reverse Merger | Pharmaceuticals |
Point Therapeutics Exits (1)
Point Therapeutics’s most recent exit was on 12-Feb-2008 from Fortovia Therapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Fortovia Therapeutics | 12-Feb-2008 | Completed |
|
Point Therapeutics FAQs
-
When was Point Therapeutics founded?
Point Therapeutics was founded in 1993.
-
Where is Point Therapeutics headquartered?
Point Therapeutics is headquartered in Wellesley, MA.
-
What industry is Point Therapeutics in?
Point Therapeutics’s primary industry is Drug Discovery.
-
Is Point Therapeutics a private or public company?
Point Therapeutics is a Private company.
-
What is Point Therapeutics’s current revenue?
The current revenue for Point Therapeutics is .
-
When was Point Therapeutics acquired?
Point Therapeutics was acquired on 12-Feb-2008.
-
Who acquired Point Therapeutics?
Point Therapeutics was acquired by Fortovia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
